• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[使用Respirgard II输送戊烷脒气雾剂时应使用哪种压缩机?]

[Which compressor should be used to deliver pentamidine aerosols with the Respirgard II?].

作者信息

Landman R, Faurisson F, Becquemin M H, Bouchikhi A, Girard P M

机构信息

Inserm Unité 13, Hôpital Claude-Bernard, Paris.

出版信息

Rev Mal Respir. 1991;8(4):391-5.

PMID:1924976
Abstract

Prophylaxis against pneumonia due to Pneumocystis carinii is most often carried out using pentamidine administered as an aerosol. For reasons both of comfort and cost this technique should be developed at home or at least in an extra-hospital environment. Using the Respirgard II as the nebuliser of reference this requires a compressor. We have assessed four different compressors and compared these to pressurised oxygen used in a hospital environment. During the course of nebulisation with a pentamidine aerosol two physical factors may coincide to limit their efficacy. First the deposition of some of the particles on the walls of the apparatus and secondly the production of a particle size which is incompatible with alveolar deposition. This study showed that according to the source of compressed air: 1) the fraction of the pentamidine solution found in an aerosol at the mouthpiece varies from 29 to 62%; 2) the fraction of the aerosol whose particle size is suitable for alveolar deposition (1 to 3 microns) varies from 35 to 48%. The product of these two fractions enables an assessment of the efficiency of each apparatus: 14 to 24% of the pentamidine solution may be deposited at the alveolar level. In addition to this efficiency the duration of the session (from 25 to 50 minutes) for each machine should be taken into consideration when considering the choice of the compressor to be coupled with the Respirgard II in order to improve the comfort and therefore the compliance to the treatment.

摘要

针对卡氏肺孢子虫肺炎的预防通常采用雾化吸入戊烷脒的方式。出于舒适性和成本方面的考虑,这种技术应在家庭中开展,或者至少在院外环境中进行。以Respirgard II作为参考雾化器,这需要一台压缩机。我们评估了四种不同的压缩机,并将它们与医院环境中使用的加压氧气进行了比较。在用戊烷脒气雾剂雾化的过程中,两个物理因素可能同时出现,从而限制其效果。首先,一些颗粒会沉积在仪器壁上,其次,会产生与肺泡沉积不相容的粒径。这项研究表明,根据压缩空气的来源:1)在吸嘴处气雾剂中发现的戊烷脒溶液比例在29%至62%之间变化;2)粒径适合肺泡沉积(1至3微米)的气雾剂比例在35%至48%之间变化。这两个比例的乘积可以评估每个仪器的效率:14%至24%的戊烷脒溶液可能会沉积在肺泡水平。除了这种效率之外,在考虑选择与Respirgard II配套的压缩机时,还应考虑每台机器的雾化时间(25至50分钟),以提高舒适性,从而提高治疗的依从性。

相似文献

1
[Which compressor should be used to deliver pentamidine aerosols with the Respirgard II?].[使用Respirgard II输送戊烷脒气雾剂时应使用哪种压缩机?]
Rev Mal Respir. 1991;8(4):391-5.
2
Direct isotopic assessment of aerosolized pentamidine deposition: influence of nebuliser.雾化喷他脒沉积的直接同位素评估:雾化器的影响。
Eur J Med. 1993 Oct-Nov;2(8):484-8.
3
Measurement of particle and mass distribution of pentamidine aerosol by ultrasonic and air jet nebulizers.用超声雾化器和空气喷射雾化器测量喷他脒气雾剂的颗粒和质量分布。
J Aerosol Med. 1992 Summer;5(2):65-79. doi: 10.1089/jam.1992.5.65.
4
Comparison of nebuliser efficiency for aerosolizing pentamidine.雾化喷他脒的雾化器效率比较。
J Pharm Pharmacol. 1992 Jan;44(1):7-9. doi: 10.1111/j.2042-7158.1992.tb14353.x.
5
[Lung deposition of 300 and 600 mg pentamidine, inhaled with 3 different inhalers].[使用3种不同吸入器吸入300毫克和600毫克喷他脒后的肺部沉积情况]
Med Klin (Munich). 1990 Apr;85 Suppl 2:251-4.
6
Alveolar targeting of aerosol pentamidine. Toward a rational delivery system.雾化喷他脒的肺泡靶向性。迈向合理的给药系统。
Am Rev Respir Dis. 1990 Apr;141(4 Pt 1):827-9. doi: 10.1164/ajrccm/141.4_Pt_1.827.
7
Which apparatus for inhaled pentamidine? A comparison of pulmonary deposition via eight nebulisers.哪种戊烷脒吸入装置?八种雾化器的肺部沉积比较。
Eur Respir J. 1991 May;4(5):616-22.
8
Delivered dose and regional distribution of aerosolized pentamidine using different delivery systems.使用不同给药系统时雾化喷他脒的递送剂量和区域分布。
Chest. 1991 May;99(5):1139-44. doi: 10.1378/chest.99.5.1139.
9
Pulmonary deposition of aerosolised pentamidine using a new nebuliser: efficiency measurements in vitro and in vivo.使用新型雾化器进行雾化喷他脒的肺部沉积:体内外效率测量
Eur J Nucl Med. 1994 May;21(5):399-406. doi: 10.1007/BF00171414.
10
Pulmonary deposition of nebulised pentamidine isethionate: effect of nebuliser type, dose, and volume of fill.雾化吸入的乙磺半胱氨酸戊烷脒的肺部沉积:雾化器类型、剂量和填充体积的影响。
Thorax. 1990 Jun;45(6):460-4. doi: 10.1136/thx.45.6.460.